Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effectiveness of Intradiscal Cell Therapy (IDCT) for one-level, symptomatic lumbar degenerative disc disease is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IDCT

Snippet

Sponsor: DiscGenics, Inc. | Conditions: Degenerative Disc Disease | Phase 3 | Status: RECRUITING